"CD55 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
GPI-linked membrane proteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 CONVERTASE or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.
| Descriptor ID |
D018958
|
| MeSH Number(s) |
D12.776.395.550.448.130 D12.776.543.484.500.130 D12.776.543.550.418.130
|
| Concept/Terms |
CD55 Antigens- CD55 Antigens
- CD55 Antigen
- Complement Decay-Accelerating Factor
- Complement Decay Accelerating Factor
- Decay-Accelerating Factor, Complement
- Antigens, CD55
- Decay-Accelerating Factor
- Decay Accelerating Factor
|
Below are MeSH descriptors whose meaning is more general than "CD55 Antigens".
Below are MeSH descriptors whose meaning is more specific than "CD55 Antigens".
This graph shows the total number of publications written about "CD55 Antigens" by people in this website by year, and whether "CD55 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD55 Antigens" by people in Profiles.
-
Bellone S, Roque D, Cocco E, Gasparrini S, Bortolomai I, Buza N, Abu-Khalaf M, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy. Br J Cancer. 2012 Apr 24; 106(9):1543-50.
-
Premkumar DR, Fukuoka Y, Sevlever D, Brunschwig E, Rosenberry TL, Tykocinski ML, Medof ME. Properties of exogenously added GPI-anchored proteins following their incorporation into cells. J Cell Biochem. 2001; 82(2):234-45.
-
Geho DH, Fayen JD, Jackman RM, Moody DB, Porcelli SA, Tykocinski ML. Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1c. J Immunol. 2000 Aug 01; 165(3):1272-7.
-
Lin SS, Weidner BC, Byrne GW, Diamond LE, Lawson JH, Hoopes CW, Daniels LJ, Daggett CW, Parker W, Harland RC, Davis RD, Bollinger RR, Logan JS, Platt JL. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest. 1998 Apr 15; 101(8):1745-56.
-
Meyerson HJ, Huang JH, Fayen JD, Tsao HM, Getty RR, Greenspan NS, Tykocinski ML. Functional dissociation of CD8 alpha's Ig homologue and connecting peptide domains. J Immunol. 1996 Jan 15; 156(2):574-84.
-
Liang X, Tang M, Zamb TJ, Babiuk LA, Kowalski J, Tykocinski ML. Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor. J Virol. 1993 Aug; 67(8):4896-904.
-
Lass JH, Walter EI, Burris TE, Grossniklaus HE, Roat MI, Skelnik DL, Needham L, Singer M, Medof ME. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci. 1990 Jun; 31(6):1136-48.
-
Tykocinski ML, Shu HK, Ayers DJ, Walter EI, Getty RR, Groger RK, Hauer CA, Medof ME. Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNA. Proc Natl Acad Sci U S A. 1988 May; 85(10):3555-9.